Two Sigma Investments’s MaxCyte MXCT Stock Holding History

Two Sigma Investments’s Portfolio MXCT Stock Details MXCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$427K	Buy	608,162 +520,244	+592%	+$486K	﹤0.01%	3834
2025 Q4	$136K	Buy	+87,918	New	+$140K	﹤0.01%	3819
2024 Q3	–	Sell	-23,406	Closed	-$91.8K	–	3263
2024 Q2	$91.8K	Sell	23,406 -62,944	-73%	-$271K	﹤0.01%	2833
2024 Q1	$362K	Sell	86,350 -66,010	-43%	-$310K	﹤0.01%	2478
2023 Q4	$716K	Buy	+152,360	New	+$593K	﹤0.01%	2269
2023 Q3	–	Sell	-15,661	Closed	-$71.9K	–	3119
2023 Q2	$71.9K	Buy	+15,661	New	+$72K	﹤0.01%	2788
2022 Q3	–	Sell	-56,294	Closed	-$266K	–	2692
2022 Q2	$266K	Buy	56,294 +26,591	+90%	+$131K	﹤0.01%	2069
2022 Q1	$208K	Buy	29,703 +7,408	+33%	+$50.6K	﹤0.01%	2327
2021 Q4	$227K	Buy	22,295 +10,652	+91%	+$114K	﹤0.01%	3835
2021 Q3	$142K	Buy	+11,643	New	+$176K	﹤0.01%	4036

Other funds holding MXCT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CFM

Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return

Vitruvian Partners London, United Kingdom $112M AUM 2.02% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Mudita Advisors London, United Kingdom $490M AUM 66.64% 1-Year Est. Return

BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFM

Brooklands Fund Management London, United Kingdom $88.9M AUM

Two Sigma Investments's MXCT Position: Q1 2026 in Review

Two Sigma Investments increased its MaxCyte (MXCT) stake by 592% in Q1 2026, buying an estimated $486K and bringing the position to 608,162 shares worth $427K. The position accounts for ﹤0.01% of the portfolio, ranked #3834.

Two Sigma Investments first reported a position in MXCT in Q3 2021 and has held it in 10 quarters since. The position peaked at $716K in Q4 2023. 130 funds tracked by Wall St. Rank hold MXCT as of Q1 2026.

Two Sigma Investments held 608,162 shares of MaxCyte worth $427K as of Q1 2026.
Two Sigma Investments bought 520,244 MaxCyte shares in Q1 2026, an estimated $486K.
MaxCyte made up ﹤0.01% of Two Sigma Investments's portfolio in Q1 2026, its #3834 holding.
Two Sigma Investments first reported a position in MaxCyte in Q3 2021 and has held it in 10 quarters since.
Two Sigma Investments's MaxCyte position peaked at $716K in Q4 2023.
130 funds tracked by Wall St. Rank held MaxCyte as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.